GlassScriptPhysician profile
Ann M Sullivan
NPI 1104971274
$3,098.61
in general payments reported to CMS, 2019-2025
29 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $319 · 2021: $529 · 2022: $553 · 2023: $713 · 2024: $440 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.24 |
| Education | $189.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $745.02 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $415.77 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $281.79 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $206.80 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $172.14 | 2022-2024 | |
| Exeltis, USA INC. | $168.86 | 2021-2024 | Slynd, Tyblume |
| Myovant Sciences INC. | $153.85 | 2021-2022 | |
| Coopersurgical, INC. | $128.01 | 2020-2024 | Advincula Delineator Uterine Manipulator, Paragard T 380a, Paragard T 380a |
| Meditrina | $105.41 | 2022 | |
| Therapeuticsmd, INC. | $101.14 | 2020-2022 | |
| Pfizer INC. | $78.23 | 2021-2023 | |
| Organon LLC | $66.82 | 2022-2024 | Nexplanon |
| Daiichi Sankyo INC. | $61.85 | 2021 | |
| Hologic Sales and Service, LLC | $61.65 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Intuitive Surgical, INC. | $55.43 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.83 | 2019-2021 | |
| Avion Pharmaceuticals | $30.10 | 2021-2022 | |
| Medtronic, INC. | $29.42 | 2024 | V-Loc 180 |
| Agile Therapeutics, INC. | $29.01 | 2021 | |
| Conmed Corporation | $22.73 | 2024 | Airseal |
| Allergan, INC. | $22.28 | 2019 | |
| Biogen, INC. | $19.72 | 2024 | |
| Karl Storz Endoscopy-America | $17.81 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.56 | 2021 | |
| Exact Sciences Corporation | $17.18 | 2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $16.22 | 2022 | |
| Novo Nordisk INC | $13.13 | 2023 | Ozempic, Rybelsus |
| Duchesnay USA Incorporated | $12.63 | 2019 | |
| Currax Pharmaceuticals LLC | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.